Newsroom

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) is continuing its operations at its northern Saskatchewan sites amidst wildfires that are impacting parts of the province. Currently, there are no fires in the vicinity of Cameco’s operations at Cigar Lake, Key Lake, McArthur River and Rabbit Lake. There is no risk to our sites, and they remain safe for staff. Orano’s McClean Lake mill remains operational. We are managing some temporary disruptions due to wildfires impacting...

LEXINGTON, Massachusetts (États-Unis)--(BUSINESS WIRE)--Agenus Inc. (Nasdaq : AGEN), un leader dans l'innovation en immuno-oncologie, a annoncé ce jour la signature d'accords de partenariat définitifs avec Zydus Lifesciences Ltd. (NSE : ZYDUSLIFE) ainsi que ses filiales et sociétés apparentées (ci-après « Zydus »), visant à accélérer le développement clinique, à augmenter les capacités de production et à étendre l'accès des patients au botensilimab et au balstilimab (BOT/BAL). Cette collaborati...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), líder en innovación en inmunooncología, anunció hoy que ha firmado acuerdos de asociación definitivos con Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), incluidas sus subsidiarias/afiliadas, en adelante denominadas “Zydus”, destinados a acelerar el desarrollo clínico, escalar la fabricación global y expandir el acceso de los pacientes a botensilimab y balstilimab (BOT/BAL). La colaboración estratégica incluye el intercambio de las instal...

LEXINGTON, Massachusetts--(BUSINESS WIRE)--Agenus Inc. ( Nasdaq: AGEN), ein führendes Unternehmen im Bereich der immunonkologischen Innovation, gab heute bekannt, dass es endgültige Partnerschaftsvereinbarungen mit Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), einschließlich ihrer Tochtergesellschaften/verbundenen Unternehmen, im Folgenden als „Zydus“ bezeichnet, um die klinische Entwicklung zu beschleunigen, die weltweite Produktion auszuweiten und den Zugang von Patienten zu Botensilimab und Bals...

LEXINGTON, Massachusetts--(BUSINESS WIRE)--A Agenus Inc. (Nasdaq: AGEN), líder em inovação em imuno-oncologia, anunciou hoje que assinou acordos definitivos de parceria com a Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), incluindo suas subsidiárias/afiliadas, denominada aqui “Zydus”, com o objetivo de acelerar o desenvolvimento clínico, ampliar a produção global e expandir o acesso dos pacientes ao botensilimabe e ao balstilimabe (BOT/BAL). A colaboração estratégica inclui uma troca das instalações...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), een leider in innovatie op het gebied van immuno-oncologie, heeft vandaag aangekondigd dat het definitieve samenwerkingsovereenkomsten heeft getekend met Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), inclusief haar dochterondernemingen / gelieerde ondernemingen, hierna te noemen 'Zydus,' bedoeld om de klinische ontwikkeling te versnellen, de wereldwijde productie op te schalen en de toegang van patiënten tot botensilimab en balstilimab...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), azienda leader nell'innovazione immuno-oncologica, oggi ha annunciato di aver firmato accordi definitivi di collaborazione con Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), comprese le sue affiliate/controllate, di seguito “Zydus,” progettate per accelerare lo sviluppo clinico, scalare la produzione globale e ampliare l'accesso dei pazienti a botensilimab e balstilimab (BOT/BAL). Il testo originale del presente annuncio, redatto nella l...

NEW YORK--(BUSINESS WIRE)--Maison Orveda on Madison Avenue, the wellness sanctuary of the French multi-award-winning biotech skincare brand, hosted an intimate conversation between Marc Jacobs, one of the most recognized names in design, fashion, and beauty, and Bridget Foley, fashion journalist and author. The evening also commemorated the 20th anniversary of Marc Jacobs, the designer’s landmark book published by Assouline, celebrating two decades of cultural influence and creative vision. Ref...

HONG KONG--(BUSINESS WIRE)--AM Best has maintained its stable outlook on South Korea’s non-life insurance segment, noting a continued refinement of the country’s domestic solvency standards that have helped strengthen insurers’ capital management. Additional factors include moderate growth in the long-term and general insurance segments, and efforts to improve profitability in the former as well as in investment strategies. However, AM Best notes an offsetting factor of slow growth prospects an...

SAN FRANCISCO--(BUSINESS WIRE)--Hanabi AI, a pioneering voice technology startup, today announced OpenAudio S1, the world’s first AI voice actor and a breakthrough generative voice model that delivers unprecedented real-time emotional and tonal control. Moving beyond the limitations of traditional text-to-speech solutions, OpenAudio S1 creates nuanced, emotionally authentic vocal output that captures the full spectrum of human expression. The OpenAudio S1 model is available in open beta today o...